DR. GHOLAM A PEYMAN, MD
Medical Practice at R H Johnson Blvd, Sun City, AZ
License number
Arizona 31729
Category
Medical Practice
Type
Ophthalmology
License number
Arizona 31729
Category
Medical Practice
Type
Retina Specialist
Address
Address
19052 N R H Johnson Blvd, Sun City, AZ 85375
Phone
(623) 474-3937
(623) 975-7005 (Fax)
(623) 975-7005 (Fax)
Personal information
See more information about GHOLAM A PEYMAN at radaris.comName
Address
Phone
10650 Tropicana Cir, Sun City, AZ 85351
10832 Saratoga Cir, Sun City, AZ 85351
10407 W White Mountain Rd, Sun City, AZ 85351
1518 W Orangewood Ave, Phoenix, AZ 85021
Organization information
See more information about GHOLAM A PEYMAN at bizstanding.comArizona Retinal Specialists
19052 N R H Johnson Blvd, Sun City West, AZ 85375
Doing business as:
Arizona Retinal Specialists - Gholam A Peyman MD<br>Arizona Retinal Specialists - Mandi D Conway MD
Phone:
(623) 474-3937 (Phone), (623) 975-2020 (Phone)
Categories:
Contact Lenses, General Surgeons, Ophthalmology Physicians & Surgeons, ...
Professional information
Sub-Mucosal Agent Delivery, Apparatus, System And Method
US Patent:
2011025, Oct 13, 2011
Filed:
Feb 10, 2011
Appl. No.:
12/931834
Inventors:
Gholam A. Peyman - Sun City AZ, US
International Classification:
A61F 9/007, A61M 5/30, A61M 5/31
US Classification:
604506, 604500, 604 68, 604131
Abstract:
An agent delivery apparatus for administering a pharmacological agent formulation to a sub-mucosal compartment of a body organ, comprising injector means having an internal formulation chamber that is adapted to receive and contain the pharmacological agent formulation therein and an elongated agent delivery member having a first end that is in communication with the internal formulation chamber and a second ejection end, the injector means including force generating means that is adapted to generate sufficient force to expel the pharmacological agent formulation from the injector means and into and through the agent delivery member, and out of the ejection end of the elongated agent delivery member. In one embodiment of the invention, the delivery-member comprises a needleless delivery member.
Delivery Of An Agent To Ameliorate Inflammation
US Patent:
2007007, Mar 29, 2007
Filed:
Feb 6, 2006
Appl. No.:
11/348017
Inventors:
Gholam Peyman - Sun City AZ, US
International Classification:
A61K 48/00, A61K 39/395, A61K 31/56
US Classification:
424155100, 424145100, 514044000, 514171000
Abstract:
A method delivering an anti-vascular endothelial growth factor (VEGF) agent to ameliorate inflammation at a site in the body that may be the eye, a joint, the brain, etc. or to reduce corneal neovascularization. In one embodiment, one or more other agents, such as non-steroidal anti-inflammatory agents, steroids, etc., may be included with the anti-VEGF agent. The anti-VEGF agent may be bevacizumab, ranibizumab, sunitinib maleate, pegaptanib, etc.
Method And Composition For Hyperthermally Treating Cells
US Patent:
2012014, Jun 7, 2012
Filed:
Jan 30, 2012
Appl. No.:
13/361786
Inventors:
Gholam A. Peyman - Sun City AZ, US
International Classification:
A61M 37/00, A61N 2/06, A61B 5/055, A61B 8/00, A61N 5/00, A61N 2/02, A61B 6/00, B82Y 5/00
US Classification:
600411, 604500, 600 13, 600 9, 600407, 600427, 600439, 600476, 600 1, 977774
Abstract:
A method and composition for hyperthermally diagnosing and monitoring treatment of cells with photoacoustic sound and nanoparticles. The heat (temperature) and photoacoustic sound wave production inside the target tissue is measured. The desired temperature is achieved using a laser and photoacoustic imaging technique. Hyperthermia treatment of tissue applies a heat source to kill cells without protein denaturation. The hyperthermia treatment may further comprise platelet-derived treatment. The method introduces an encapsulated dye that is released at a selected temperature in the target site to indicate that a threshold temperature has been reached to hyperthermally treat the tissue. The temperature to which the target site is treated ranges from about 39° C. to about 58° C., and may last from about 5 seconds to about 30 minutes. The composition which can be a liposome composition encapsulating the dye can be introduced to the bloodstream to flow through the target site.
Ophthalmic Drug Delivery System And Method
US Patent:
2012021, Aug 23, 2012
Filed:
Apr 27, 2012
Appl. No.:
13/457568
Inventors:
Gholam A. Peyman - Sun City AZ, US
International Classification:
A61F 2/14, A61P 27/02
US Classification:
424428
Abstract:
A method to provide a therapeutic agent to an eye of a patient by implanting or inject a device that stably fits a particular location or position in the eye. The method thus provides agent inside the eye for a longer duration of agent release over a space-occupying area inside the eye.
Method For Prevention Of Rejection And Sever Encapsulation Of A Supportive Or Functioning Implant
US Patent:
2010011, May 6, 2010
Filed:
Oct 29, 2009
Appl. No.:
12/608249
Inventors:
Gholam A. PEYMAN - Sun City AZ, US
International Classification:
A61F 9/013
US Classification:
606107
Abstract:
A method of preventing rejection of an implant in the eye, includes forming a flap in the cornea of the eye, inserting an implant under the flap, cross linking corneal tissue surrounding an implant to make the corneal tissue surrounding an implant less vulnerable to enzymatic degradation, inserting polymeric material under the corneal flap so as to overlie corneal tissue, compressing a layer of the cornea from outside using a lens having a predetermined curvature to correct refractive error of the cornea, and cross linking corneal tissue that the polymeric material overlies.
Method And Composition For Hyperthermally Treating Cells
US Patent:
2013000, Jan 3, 2013
Filed:
Sep 11, 2012
Appl. No.:
13/610503
Inventors:
Gholam A. Peyman - Sun City AZ, US
International Classification:
A61M 37/00, B82Y 5/00
US Classification:
600 9, 604500, 604 20, 604 22, 977773, 977915
Abstract:
A method and composition for hyperthermally treating tumor cells in a patient under conditions that affect tumor stem cells and tumor cells. In one embodiment, the method provides a synergistic effect with chemotherapy.
Method And Composition For Hyperthermally Treating Cells
US Patent:
2013006, Mar 14, 2013
Filed:
Oct 31, 2012
Appl. No.:
13/665458
Inventors:
Gholam A. Peyman - Sun City AZ, US
International Classification:
A61N 5/10, A61B 6/00, A61N 2/00, A61N 1/40, A61N 7/02
US Classification:
600407, 600 2, 977773, 977906
Abstract:
A method and composition for hyperthermally treating tumor cells in a patient under conditions that affect tumor stem cells and tumor cells. In one embodiment, the method is administered in combination with localized internal ionizing radiation therapy.
Transition Lenses With Virtual Pupil
US Patent:
2010023, Sep 16, 2010
Filed:
Feb 16, 2010
Appl. No.:
12/706369
Inventors:
Gholam A. Peyman - Sun City AZ, US
International Classification:
A61F 2/16
US Classification:
623 617
Abstract:
A lens containing a chromophore distributed in or on the lens such that the lens functions as a virtual pupil in adjusting to light. The lens can be intraocular or extraocular.
Transition Lenses With Virtual Pupil
US Patent:
2011015, Jun 30, 2011
Filed:
Feb 24, 2011
Appl. No.:
13/034423
Inventors:
Gholam A. Peyman - Sun City AZ, US
International Classification:
G02C 7/10, G02C 9/00
US Classification:
351 47, 351 44
Abstract:
A lens containing a chromophore distributed in or on the lens such that the lens functions as a virtual pupil in adjusting to light. The lens can be intraocular or extraocular.
Photoacoustic Measurement
US Patent:
2012027, Oct 25, 2012
Filed:
Jun 28, 2012
Appl. No.:
13/536391
Inventors:
Gholam A. Peyman - Sun City AZ, US
International Classification:
A61N 5/067, A61N 7/00, A61N 5/06
US Classification:
601 2, 607 89, 607 88
Abstract:
A method of providing cosmetic treatment of a skin surface of a patient using a photoacoustic system.